We evaluated the day-to-day variability of transcutaneous oxygen tension (tcPO 2 ) in patients with diabetes mellitus and peripheral arterial occlusive disease who were at risk for chronic foot ulceration. Methods: The tcPO 2 was measured in the morning once daily for 3 consecutive days in 10 male patients with diabetes mellitus who were hospitalized. The mean age of the patients was 65 ± 13 years, and they had a mean duration of diabetes mellitus of 33 ± 6 years. The tcPO 2 was measured at a reference point at the chest (I 2 dx), the dorsum of the foot, and in the first intermetatarsal space. Measurements of tcPO 2 in the first intermetatarsal space were performed before and during inhalation of 100% oxygen. Results: The mean tcPO 2 was higher (P < .001) at I 2 dx (56 ± 10 mm Hg) than at the dorsum of the foot (25 ± 19 mm Hg) and first intermetatarsal space (27 ± 20 mm Hg). tcPO 2 increased (P < .001) during inhalation of 100% oxygen, whereas the increase was severely reduced in three patients with tcPO 2 less than 10 mm Hg at baseline. A reasonably good day-to-day variability of tcPO 2 was seen; the linear relations between tcPO 2 investigated on days 1, 2, and 3 were highly significant (P = .0001) at each measuring site, and no systematic differences were seen between the repeated measurements (analysis of variance; P = .13 to .85).
investigations in the prediction of the outcome of chronic foot ulcers. 15 The reproducibility of tcPO 2 was investigated earlier in healthy volunteers and in patients with PAOD and seems acceptable when the measurements are performed during submaximal vasodilatation by heating the investigated skin area to a core temperature of 44°C. 9, [16] [17] [18] [19] However, in patients with PAOD and chronic foot ulcers, the disturbances in skin microcirculation may differ from one skin area to another. 20 The aim of this study was to investigate tcPO 2 in two different skin areas at the foot dorsum and to investigate the day-to-day variability of tcPO 2 in patients with diabetes mellitus and PAOD who are at risk for chronic foot ulceration. The day-to-day variability of tcPO 2 during inhalation of 100% oxygen was also investigated, because the predictive value of tcPO 2 for ulcer healing may be enhanced by this procedure. 14 
METHODS
Patients. Ten male patients with type 2 diabetes mellitus and PAOD were studied. Eight patients had had chronic foot ulcers for more than 8 weeks, and two patients had a history of earlier foot ulceration. The mean age of the patients was 65 ± 13 years, and the mean duration of diabetes mellitus in the patients was 33 ± 6 years. Four patients were smokers, and six patients were exsmokers. All patients were treated with insulin two to four times daily. One patient had undergone vascular reconstruction 5 weeks before the investigations. Because of the extensive distal nature of the PAOD or the PAOD and an increased operative risk, the patients were not eligible for reconstructive vascular surgery or angioplasty. None of the patients had any clinical signs of ongoing acute infection.
Chronic foot ulceration is a severe complication in patients with diabetes mellitus, and 10% to 15% of these lesions deteriorate, leading to minor or major amputation of the limb. 1,2 Peripheral arterial occlusive disease (PAOD) is a common cause of chronic foot ulcers, 1,2 and the impaired tissue oxygenation is further deteriorated by disturbances in skin microcirculation of the diabetic foot. 3, 4 These disturbances are characterized by an impaired capillary blood circulation, which is more pronounced when the demand of tissue nutrition and oxygenation is increased. 3, 4 This "chronic capillary ischemia" can be demonstrated early after the onset of diabetes mellitus, is more pronounced when other diabetic complications are present, 4 and may be one explanation for the reduced transcutaneous oxygen tension (tcPO 2 ) shown in patients with diabetes mellitus. [5] [6] [7] The tcPO 2 is a noninvasive method reflecting local arterial skin blood flow and oxygenation 8 and can be used as a means of determining severity and clinical progression of PAOD, chronic foot ulceration, or both. [9] [10] [11] [12] The tcPO 2 is also a useful means of determining the optimal amputation level 8, 9, 13, 14 and can be a complement to macrocirculatory Examining procedure. Measurements of tcPO 2 , systolic and diastolic arm blood pressures, and systolic toe blood pressure were performed on three consecutive days (days 1, 2, and 3) at the Microcirculatory Laboratory of Karolinska Hospital. The measurements were made in the morning after the patients had eaten a light breakfast and approximately 90 minutes after insulin injection. The patients were asked to refrain from smoking and drinking coffee for at least 2 hours before the examinations. No change in the medical treatment was made during the study period. tcPO 2 and peripheral blood pressure were measured with the patient in the supine position, after an acclimatization period of 20 minutes. The room temperature was kept between 22°C and 24°C. If the patient had foot ulceration, the foot with ulceration was chosen for the examinations.
Blood pressure measurement. Systolic and diastolic arm blood pressures (mm Hg) were measured by means of the Riva Rocci method. The systolic toe blood pressure was assessed by recording the pressure (mm Hg) with a miniature cuff (2 cm wide) placed around the base of the great toe, in which return of blood was shown by means of laser Doppler fluxmetry of the toe pulp when the cuff was slowly deflated from suprasystolic values. 21 This method is highly correlated (r = 0.985; P < .001) to pressure measurements with photopletysmography. 21 Transcutaneous oxygen tension. The tcPO 2 measurement was made with an electrochemical transducer (Oxykapnomonitor, SMK 363 Hellige, Freiburg im Breisgau, Germany). The monitor was calibrated against air and a zero solution, according to the manufacturer's instructions. The measurement site was cleaned carefully with disinfection solution (chlorhexidin spirit), and the probe was attached to the skin with double-sided adhesive rings and contact liquid supplied by the manufacturer. To increase the permeability of the skin to oxygen molecules at the measuring site, we heated the transducer to 44°C with a built-in sensor heater. Hyperemic stabilization occurred within 20 minutes, and the tcPO 2 signal was continuously recorded on paper. A reference value was determined by placing the transducer on the chest at the right side in the subclavicular region (I 2 dx). 8 The transducer was then placed at the dorsum of the foot (over the dorsal pedal artery), and after a measurement was taken at this point, the transducer was moved to the first intermetatarsal space. The measured skin areas were marked with ink to ensure the same measuring site at each investigation. tcPO 2 in the first intermetatarsal space was measured before and during inhalation of 100% oxygen. The patients inhaled oxygen by breathing in a plastic hood supplied with oxygen for 15 to 20 minutes. After an inhalation period of 5 to 10 minutes, a tcPO 2 plateau was reached and was registered as the tcPO 2 level during inhalation of 100% oxygen. None of the tcPO 2 measurements were performed with direct contact with any foot ulceration.
Statistical analysis. Data of peripheral blood pressures are given as mean ± SD in Table I . The results of tcPO 2 are shown in Table II as mean ± SD, and the mean tcPO 2 for days 1 through 3 was determined. The difference in tcPO 2 between different measuring sites was investigated by means of the paired t test with the Bonferroni correction. The means of the systolic toe blood pressures and tcPO 2 values at the foot were calculated in each patient and plotted against each other in a scattergram, and the linear relation was determined (Fig 1) . The repro- ducibility was investigated by means of regression analyses and 1-factor analysis of variance with repeated measures, and the data are shown in Figs 2 and 3 and are given in the "Results" section. A P value less than .05 was considered to be significant. For each patient, the within SD (SD within ) and mean were calculated for the three repeated measurements of tcPO 2 . The within SDs and means were then averaged for the patients. Mean and approximate 95% CIs for the within variation were given by means of these estimates as mean ± 2*SD within . These data are given in Table III .
RESULTS
Peripheral blood pressure. The toe/arm blood pressure index was less than 0.7 in all patients. Significant linear relations between the systolic toe blood pressures measured on days 1, 2, and 3 (r 2 = 0.89-0.93; P < .001) was shown by means of regression analysis, and no systematic difference (analysis of variance; P = .42) was seen between the repeated measurements.
Transcutaneous oxygen tension. The tcPO 2 measured at the reference point (I 2 dx) was higher (P < .01) than that measured at the dorsum of the foot and in the first intermetatarsal space, whereas there was no significant JOURNAL OF VASCULAR SURGERY Volume 34, Number 2 Jörneskog, Djavani, and Brismar 279 difference (P = .489) between tcPO 2 measured at the dorsum of the foot and that measured in the first intermetatarsal space. tcPO 2 in the first intermetatarsal space increased (P < .001) significantly during inhalation of 100% oxygen, and the increase was more than 400% in seven patients (without oxygen, 37 ± 11 mm Hg; with oxygen, 243 ± 58 mm Hg). The tcPO 2 level during inhalation of 100% oxygen was considerably lower (4-33 mm Hg) in three patients with severely reduced tcPO 2 at baseline (< 10 mm Hg). No significant linear relation (r 2 = 0.06, P = .42) was seen between mean systolic toe blood pressure and mean tcPO 2 at the foot (Fig 1) .
Day-to-day variability of tcPO 2 . Highly significant relations were shown by means of regression analyses between tcPO 2 determined on days 1, 2, and 3 at each measuring site: I 2 dx (r 2 = 0.75-0.82; P < .01); dorsum of the foot (Fig 2; r 2 = 0.89-0.96; P < .001); first intermetatarsal space before inhalation of 100% oxygen (r 2 = 0.91-0.94; P < .001); first intermetatarsal space during inhalation of 100% oxygen (r 2 = 0.91-0.95; P < .001). No systematic differences were observed between the repeated measurements of tcPO 2 on days 1, 2, and 3 (analysis of variance; P = .17, .62, .85, .13, respectively).
Highly significant linear relations (r 2 = 0.73-0.98; P < The values are presented as mean ± SD.
.01) were seen between the lowest and highest tcPO 2 values at each measuring point (Fig 3) . Mean and approximate 95% CIs for the within variation of the tcPO 2 measurements are shown in Table III . Although the CIs are formed for single new observations for the variables in Table III , the lengths of the intervals seem to be rather narrow, indicating a reasonably good day-to-day variability of tcPO 2 .
DISCUSSION
In this study, the day-to-day variability of tcPO 2 was investigated in 10 patients with diabetes mellitus and PAOD. All patients were at high risk for chronic foot ulceration; 8 patients had chronic foot ulcers, and the other 2 patients had a history of chronic foot ulcers. The tcPO 2 was measured in three different skin areas, the chest, the dorsum of the foot, and in the first intermetatarsal space.
The measurement of tcPO 2 reflects the amount of oxygen available in skin microcirculation during local hyperemia and is dependent on both central and local factors. The central factors may be systolic arterial blood pressure and arterial oxygen content, which are influenced by such factors as heart failure and respiratory diseases, whereas the local factors, such as local blood flow, local oxygen consumption, and diffusion, are influenced by such factors as angiopathy, infection, edema, and skin thickness. tcPO 2 in patients with diabetes mellitus is generally somewhat lower than in age-matched control subjects who do not have diabetes mellitus, even in patients with a short duration of diabetes mellitus and without macrovascular complications. [5] [6] [7] In patients with PAOD, tcPO 2 can be very low or close to 0, and it has been suggested that these findings do not necessarily mean total skin anoxia, but rather that the amount of oxygen molecules available at the skin surface is too low for consumption by the electrode. 9, 22 The metabolic demand of skin tissue is low, and skin tissue can sometimes survive despite severely impaired blood circulation. However, tcPO 2 levels less than 10 mm Hg are most often associated with a bad outcome, such as impaired ulcer healing, amputation, or both. 9, 15 The results of the current study are in line with other investigations showing a reduced tcPO 2 at the foot level in patients with diabetes mellitus and PAOD, 8, 9 which indicates that oxygen delivery to the skin is mainly a flowrelated phenomenon. Franzeck et al 9 investigated tcPO 2 in healthy subjects and in patients with PAOD. In the healthy subjects, tcPO 2 varied between 40 and 70 mm Hg at the chest level and between 30 and 70 mm Hg at the foot. In the patients with PAOD, tcPO 2 at the chest level was between 30 and 80 mm Hg, whereas tcPO 2 at the foot varied considerably (0-70 mm Hg). In the current study, three patients showed very low tcPO 2 at baseline (< 10 mm Hg), and the responses during inhalation of 100% oxygen were also severely reduced (4-33 mm Hg) as compared with those in the other patients (170-330 mm Hg). These findings indicate an extremely impaired skin Table II . Transcutaneous oxygen tension (mm Hg) measured at a reference point (I 2 dx), the dorsum of foot, and in the first intermetatarsal space on three consecutive days (1, 2, and 3) in 10 patients with diabetes mellitus and PAOD The values are presented as mean ± SD, and the statistical analyses were performed with the paired t test with Bonferroni correction. The measurements in the first intermetatarsal space were performed before and during inhalation of 100% oxygen. *P < .01 as compared with I 2 dx. †No significant difference (P = .489) as compared with "dorsum of the foot." ‡P <.01 as compared with that without oxygen. The measurements were performed at a reference point (I 2 dx), the dorsum of the foot, and in the first intermetatarsal space before and during inhalation of 100% oxygen.
microcirculation, 8, 9, 14 a suggestion strengthened because two of these patients went on to have a major amputation within 7 weeks. The reasons for amputation were symptoms of critical ischemia and not acute infection. The third patient had undergone vascular reconstruction 5 weeks earlier and had a slight foot edema, which may explain the severely reduced tcPO 2 . 23 However, this patient underwent a major amputation 12 months later. In contrast to the microcirculatory findings, toe blood pressure indicated critical limb ischemia in only one of these three patients (ie, a systolic toe blood pressure ≤ 30 mm Hg). 24 However, two other patients had severely low toe blood pressures, whereas the tcPO 2 levels were between 30 and 50 mm Hg (Fig 1) , and none of these patients went on to have an amputation within the first year. Furthermore, the current study showed no significant relation between macrocirculation and microcirculation (Fig 1) . This discrepancy between macrovascular and microvascular findings is in agreement with the results of an earlier study by our group, 15 which also indicated that tcPO 2 is a better predictor for outcome of chronic foot ulcers than toe blood pressure. A combination of peripheral blood pressure measurements and skin microcirculatory investigations, such as systolic toe blood pressure and tcPO 2 , may provide better assessment of the prognosis than one parameter alone. 25, 26 The reproducibility of systolic toe blood pressure measurements, with laser Doppler fluxmetry as the means of detection, was also investigated in this study, and a good agreement was demonstrated between the repeated investigations ( Table I) . The tcPO 2 was measured in two adjacent skin areas at the foot because the disturbances in skin microcirculation may have a patchy distribution. 20, 27 The results showed no significant differences in tcPO 2 between these two measuring points (Table II ; P = .489), which may be because these skin areas are mainly supplied with blood from the same artery, the dorsal pedal artery.
This study shows a good day-to-day variability for tcPO 2 measured at the chest, the dorsum of the foot, and in the first intermetatarsal space both before and during inhalation of 100% oxygen (Figs 2 and 3) . These results are in line with a study by Rooke and Osmundson, 18 who reported a "relatively" good agreement of the tcPO 2 investigations when repeated 24 and 48 hours later. Lukkari-Rautiarinen et al 28 investigated the day-to-day variability of tcPO 2 in patients with "advanced distal ischemia of the lower limb" and found a coefficient of variation of 37%, which was reduced to 31% when patients with tcPO 2 less than 10 mm Hg were excluded. To eliminate the problem with patients with very low tcPO 2 values, we have chosen not to report the reproducibility with the coefficient of variation. The reason for the good reproducibility in this study is most probably that we investigated a homogenous group of hospitalized patients and the investigations were performed in a very standardized way (same time of the day, same time after medication). No significant difference in reproducibility of tcPO 2 was seen between the different measuring sites, but JOURNAL OF VASCULAR SURGERY Volume 34, Number 2 Jörneskog, Djavani, and Brismar 281 the reproducibility may be somewhat better in the first intermetatarsal space when measured without oxygen inhalation.
In summary, this study shows an acceptable day-today variability for measurement of tcPO 2 , both at baseline and during oxygen inhalation, in patients with diabetes mellitus and PAOD who are at high risk for chronic foot ulceration.
